Wednesday, December 9, 2020

New compound related to psychedelic ibogaine could treat addiction, depression

A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers.

from Top Health News -- ScienceDaily https://ift.tt/3gxFrI4
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New antibody drug stops aggressive prostate cancer from spreading

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Al...